Get the Stockscreener App
49.36
4.84%
-2.51
After Hours:
49.36
Tarsus Pharmaceuticals Inc stock is traded at $49.36, with a volume of 1.23M.
It is down -4.84% in the last 24 hours and down -3.89% over the past month.
Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.
See More
Previous Close:
$51.87
Open:
$51.26
24h Volume:
1.23M
Relative Volume:
1.87
Market Cap:
$2.08B
Revenue:
$17.39M
Net Income/Loss:
$-135.89M
P/E Ratio:
-10.64
EPS:
-4.64
Net Cash Flow:
$-123.00M
1W Performance:
-14.35%
1M Performance:
-3.89%
6M Performance:
+4.80%
1Y Performance:
+55.71%
1-Day Range:
$48.36
$51.60
1-Week Range:
$48.36
$57.51
52-Week Range:
$30.23
$59.76
Tarsus Pharmaceuticals Inc Stock (TARS) Company Profile
Name
Tarsus Pharmaceuticals Inc
Sector
Industry
Phone
(949) 409-9820
Address
15440 LAGUNA CANYON ROAD, IRVINE
Compare TARS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TARS
Tarsus Pharmaceuticals Inc
|
49.36 | 2.29B | 17.39M | -135.89M | -123.00M | -4.64 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Tarsus Pharmaceuticals Inc Stock (TARS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-02-25 | Resumed | Oppenheimer | Outperform |
| May-27-25 | Resumed | H.C. Wainwright | Buy |
| Nov-20-23 | Initiated | Goldman | Neutral |
| Jul-18-23 | Initiated | William Blair | Outperform |
| May-18-23 | Initiated | Guggenheim | Buy |
| Aug-01-22 | Initiated | Barclays | Overweight |
| Dec-21-21 | Initiated | H.C. Wainwright | Buy |
| Nov-23-21 | Initiated | Oppenheimer | Outperform |
| Nov-10-20 | Initiated | BofA Securities | Buy |
| Nov-10-20 | Initiated | Jefferies | Buy |
| Nov-10-20 | Initiated | Ladenburg Thalmann | Buy |
| Nov-10-20 | Initiated | Raymond James | Strong Buy |
View All
Tarsus Pharmaceuticals Inc Stock (TARS) Latest News
Tarsus Pharmaceuticals (NASDAQ:TARS) Director William Phd Link Sells 27,116 Shares - MarketBeat
Adage Capital Partners GP L.L.C. Purchases Shares of 510,000 Tarsus Pharmaceuticals, Inc. $TARS - MarketBeat
Tarsus Pharma director Link sells $1.55m in stock - Investing.com
Baird Financial Group Inc. Decreases Stock Position in Tarsus Pharmaceuticals, Inc. $TARS - MarketBeat
Cormorant Asset Management LP Sells 100,000 Shares of Tarsus Pharmaceuticals, Inc. $TARS - MarketBeat
Cutter Capital Management LP Boosts Stock Position in Tarsus Pharmaceuticals, Inc. $TARS - MarketBeat
Possible Bearish Signals With Tarsus Pharmaceuticals Insiders Disposing Stock - simplywall.st
Tarsus Pharmaceuticals, Inc. $TARS Shares Sold by Ally Bridge Group NY LLC - MarketBeat
Technical Models Suggest Tarsus Pharmaceuticals Inc. May Rebound SoonEarnings Overview Summary & Daily Price Action Insights - beatles.ru
Tarsus Pharmaceuticals (NASDAQ:TARS) Reaches New 12-Month HighStill a Buy? - MarketBeat
Tarsus Pharmaceuticals, Inc. $TARS Holdings Cut by Frazier Life Sciences Management L.P. - MarketBeat
Momentum divergence signals in Tarsus Pharmaceuticals Inc. chartQuarterly Portfolio Summary & Smart Allocation Stock Tips - Newser
Northern Trust Corp Boosts Holdings in Tarsus Pharmaceuticals, Inc. $TARS - MarketBeat
Custom watchlist performance reports with Tarsus Pharmaceuticals Inc.2025 Volatility Report & Verified Entry Point Signals - Newser
Tarsus Pharmaceuticals Inc. stock prediction for this weekCPI Data & Weekly Return Optimization Plans - Newser
Should you wait for a breakout in Tarsus Pharmaceuticals Inc.Quarterly Market Summary & Precise Trade Entry Recommendations - Newser
Real time breakdown of Tarsus Pharmaceuticals Inc. stock performance - Newser
Is Tarsus Pharmaceuticals Inc. stock suitable for long term investingJuly 2025 Trade Ideas & Growth Focused Stock Pick Reports - خودرو بانک
What does recent volatility data suggest for Tarsus Pharmaceuticals Inc.Jobs Report & AI Driven Stock Reports - Newser
Candlestick signals on Tarsus Pharmaceuticals Inc. stock todayMarket Volume Summary & Real-Time Volume Surge Alerts - Newser
Ghisallo Capital Management LLC Takes Position in Tarsus Pharmaceuticals, Inc. $TARS - MarketBeat
Smart tools for monitoring Tarsus Pharmaceuticals Inc.’s price actionDip Buying & Free Reliable Trade Execution Plans - Newser
Combining price and volume data for Tarsus Pharmaceuticals Inc.Quarterly Earnings Report & Consistent Profit Focused Trading Strategies - Newser
Will Tarsus Pharmaceuticals Inc. stock recover after earningsJuly 2025 Update & Stepwise Trade Signal Implementation - خودرو بانک
Driehaus Capital Management LLC Buys New Shares in Tarsus Pharmaceuticals, Inc. $TARS - MarketBeat
Is Tarsus Pharmaceuticals Inc. a cyclical or defensive stock2025 Trading Recap & Reliable Price Breakout Signals - خودرو بانک
Volatility clustering patterns for Tarsus Pharmaceuticals Inc.Portfolio Value Summary & Weekly Consistent Profit Watchlists - Newser
Tarsus Pharmaceuticals Inc. stock momentum explainedStop Loss & Daily Chart Pattern Signal Reports - Newser
Why Tarsus Pharmaceuticals Inc. is moving todayStock Surge & Reliable Momentum Entry Alerts - Newser
Technical Models Detect Momentum Build in Tarsus Pharmaceuticals Inc.2025 Technical Patterns & Weekly Setup with High ROI Potential - beatles.ru
FORA Capital LLC Buys New Stake in Tarsus Pharmaceuticals, Inc. $TARS - MarketBeat
Relative strength of Tarsus Pharmaceuticals Inc. in sector analysisJuly 2025 Sentiment & Fast Exit Strategy with Risk Control - Newser
What data driven models say about Tarsus Pharmaceuticals Inc.’s futureJuly 2025 Patterns & Fast Entry and Exit Trade Plans - Newser
Applying Elliott Wave Theory to Tarsus Pharmaceuticals Inc.July 2025 Sector Moves & Breakout Confirmation Trade Signals - Newser
Will Tarsus Pharmaceuticals Inc. bounce back from current support2025 EndofYear Setup & Daily Risk Controlled Trade Plans - Newser
Detecting support and resistance levels for Tarsus Pharmaceuticals Inc.July 2025 Gainers & Safe Capital Growth Stock Tips - Newser
Does Tarsus Pharmaceuticals Inc. have a sustainable dividendJuly 2025 Update & Growth Oriented Trading Recommendations - خودرو بانک
Using Ichimoku Cloud for Tarsus Pharmaceuticals Inc. technicals2025 Investor Takeaways & Weekly High Momentum Picks - Newser
Using portfolio simulators with Tarsus Pharmaceuticals Inc. includedSwing Trade & Technical Pattern Based Buy Signals - Newser
How liquid is Tarsus Pharmaceuticals Inc. stockLayoff News & Community Verified Trade Signals - خودرو بانک
Can Tarsus Pharmaceuticals Inc. hit a new high this monthGap Down & Weekly Watchlist for Hot Stocks - Newser
Wellington Management Group LLP Sells 20,685 Shares of Tarsus Pharmaceuticals, Inc. $TARS - MarketBeat
What technical models suggest about Tarsus Pharmaceuticals Inc.’s comeback - Newser
Published on: 2025-09-03 00:33:31 - Newser
Can momentum traders help lift Tarsus Pharmaceuticals Inc.Weekly Investment Summary & Real-Time Buy Zone Alerts - Newser
Is Tarsus Pharmaceuticals Inc. still worth holding after the dipJuly 2025 Fed Impact & Expert Approved Momentum Trade Ideas - Newser
Tarsus Pharmaceuticals stock hits 52-week high at 58.99 USD By Investing.com - Investing.com South Africa
Tarsus Pharmaceuticals Inc Stock (TARS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):